The Origins of “Confidential Commercial Information” at the FDA

The Origins of “Confidential Commercial Information” at the FDA

This Viewpoint reviews regulations regarding FDA’s handing of confidential commercial information, explains how these regulations serve as a barrier to disclosure of information in the interest of public health, and suggests how information could be carefully shared to improve health outcomes and ad...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JAMA : the journal of the American Medical Association 2024-08, Vol.332 (7), p.533-534
Hauptverfasser: Daval, C. Joseph Ross, Kesselheim, Aaron S
Format: Artikel
Sprache:eng
Schlagworte:
Confidentiality
Drug Industry
History, 20th Century
United States
United States Food and Drug Administration
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This Viewpoint reviews regulations regarding FDA’s handing of confidential commercial information, explains how these regulations serve as a barrier to disclosure of information in the interest of public health, and suggests how information could be carefully shared to improve health outcomes and advance research.
ISSN:0098-7484
1538-3598
1538-3598
DOI:10.1001/jama.2024.9639